From: Uveitic glaucoma in children: a systematic review on surgical outcomes
Criteria for success (C = complete / Q = qualified) | Success rate | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Author, Year | Type of surgery | Previous interventions | No. of Eyes | No. of Patients | Age at Surgery (yrs) | IOP (mmHg) | Meda | No. of proceduresb | Other | 1 yr | 2 yrs | ≥ 5 yrs |
Kanski and McAllister,’85 [23] | Trabeculo- dialysis | 43% CPCb,37% filtration surgery | 30 | 23 | 16 (4–36)c | < 22 | C: 0 Q: no limitation | 1 | C: 17% Q: 60% | |||
Freedman et al.,’02 [9] | Goniotomy | no | 16 | 12 | 15 (6.5–30)c | < 22, > 5 | no limitation | 1–2 | no adverse events | 1x: 72%d 2x: 79% | 1x: 54%d 2x: 75% | 1x:54%d 2x:75% |
Goniotomy | few cases had a TE before | 40 | 31 | 10.3 ± 4.7e | < 22, > 5 | no limitation | 1–3 | > 1x:92% | 1x: 61%d > 1x: 92% | 1: 47%d > 1x:81% | ||
Bohnsack and Freedman,’13 [24] | Goniotomy | no | 31 | 31 | 10.9 ± 4.4e | < 22, > 5 | no limitation | 1–2 | no adverse events | 1x: 76%d 2x: 83% | 1x: 57%d 2x: 79% | 1x: 48%d 2x: 69% |
Wang et al.,’16 [25] | Trabeculo-tomy | 18% goniotomy 7% Ahmed implant | 28 | 22 | 9.7 ± 3.6e | < 22, > 5 | no limitation | 1–2 | 1x: 81%d 2x: 86% | 1x: 69%d 2x: 77% | ||
Heinz et al.,’11 [26] | TEf | 88% CPCb | 16 | 16 | 12.7 ± 3.8 | < 22, > 5 | C: 0 Q: no limitation | 1 | C: 88% Q: 94% | |||
TEf | 61% CPCb | 21 | 17 | 13.8 ± 4e | < 15, > 5 | C: 0 Q: no limitation | 1 | C: 55% Q: 70% | C: 38% Q: 71% | |||
Leinonen et al.,’15 [28] | TEf | 24% CPCb, 7% viscocanalostomy | 15d 14f | 15d 14f | 11.8 (6.3–20.4)g,c 11.0 (3.1–16.8)c,h | < 22, > 5 | 0 | 1 | 73%g 57%h | 73%g 16%h | ||
Gautam et al.,’18 [6] | TEf | no | 13 | 9 | ≤ 16 | < 22, > 5 | C: 0 Q: no limitation | 1 | C: 54%^i Q: 23% | |||
Valimaki et al., ‘97 [29] | Molteno shunt | 52% TEh, 22% CPCb | 27 | 19 | 15.3 ± 8.7 e | < 22, > 5 | No more as used pre-opj | 1 | no loss of light perception | 95% | 89% | |
Chen et al.,’15 [22] | Ahmed implant | 24 | 9.0 ± 3.8 e | < 22, > 5 + 20% IOP reduction | no limitation | 1 + revision of GDI accepted | no adverse events | 75% | ||||
Wiese et al.,’16 [19] | Ahmed implant | 54% TEh, 45% CPCb, 27% goniotomy | 11 | 11 | 17.8 ± 6.1e | < 15, > 5 | 0 | 1 | ||||
Eksioglu et al., ‘17 [30] | Ahmed implant | 25% TEh | 16 | 11 | 14.2 ± 3.3e | < 22, > 5 | C: 0 Q: no limitation | 1 + small revisions accepted | C: 56% | C: 38% Q: 44% | ||
Heinz et al., ‘06 [31] | CPC procedure | no | 19 | 12 | 10.9 ± 3.4e | < 22 | C: 0 Q: no limitation | 1–3 | C: 0% Q: 32% |